Pharmanutra Statistics

Total Valuation

Pharmanutra has a market cap or net worth of EUR 522.67 million. The enterprise value is 529.33 million.

Market Cap	522.67M
Enterprise Value	529.33M

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Pharmanutra has 9.61 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.61M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.73%
Owned by Institutions (%)	15.75%
Float	4.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	26.35
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	26.91
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.94, with an EV/FCF ratio of 27.25.

EV / Earnings	32.53
EV / Sales	4.66
EV / EBITDA	16.94
EV / EBIT	19.67
EV / FCF	27.25

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.42.

Current Ratio	2.26
Quick Ratio	1.53
Debt / Equity	0.42
Debt / EBITDA	0.78
Debt / FCF	1.26
Interest Coverage	18.50

Financial Efficiency

Return on equity (ROE) is 29.54% and return on invested capital (ROIC) is 21.09%.

Return on Equity (ROE)	29.54%
Return on Assets (ROA)	15.10%
Return on Capital (ROIC)	21.09%
Revenue Per Employee	1.01M
Profits Per Employee	145,277
Employee Count	105
Asset Turnover	1.02
Inventory Turnover	8.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.92% in the last 52 weeks. The beta is 0.31, so Pharmanutra's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+5.92%
50-Day Moving Average	56.56
200-Day Moving Average	53.39
Relative Strength Index (RSI)	45.65
Average Volume (20 Days)	5,455

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmanutra had revenue of EUR 113.67 million and earned 16.27 million in profits.

Revenue	113.67M
Gross Profit	45.06M
Operating Income	26.91M
Pretax Income	26.36M
Net Income	16.27M
EBITDA	30.47M
EBIT	26.91M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 17.82 million in cash and 24.48 million in debt, giving a net cash position of -6.66 million or -0.69 per share.

Cash & Cash Equivalents	17.82M
Total Debt	24.48M
Net Cash	-6.66M
Net Cash Per Share	-0.69
Equity (Book Value)	58.90M
Book Value Per Share	n/a
Working Capital	35.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.87 million and capital expenditures -3.45 million, giving a free cash flow of 19.42 million.

Operating Cash Flow	22.87M
Capital Expenditures	-3.45M
Free Cash Flow	19.42M
FCF Per Share	2.02

Full Cash Flow Statement

Margins

Gross margin is 39.64%, with operating and profit margins of 23.68% and 14.31%.

Gross Margin	39.64%
Operating Margin	23.68%
Pretax Margin	23.19%
Profit Margin	14.31%
EBITDA Margin	26.80%
EBIT Margin	23.68%
FCF Margin	17.09%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 1.53%.

Dividend Per Share	0.85
Dividend Yield	1.53%
Dividend Growth (YoY)	6.25%
Years of Dividend Growth	3
Payout Ratio	50.22%
Buyback Yield	n/a
Shareholder Yield	1.53%
Earnings Yield	n/a
FCF Yield	3.72%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a